David Olson | CaringBridge

David Olson

First post: 3/1/2017 Latest post: 3/18/2017
Welcome to our CaringBridge website. We are using it to keep family and friends updated in one place. We appreciate your support and words of hope and encouragement. Thank you for visiting.
David is getting treatment at Northwestern Hospital, NWH, with Dr. Aparna Kalyan and her team. His metastatic pancreatic adenocarcinoma qualifies him for a clinical research study--a 5-drug combination. These are:
-5-Fluorouracil
-Bevacizumab
-Leucovorin
-Oxaliplatin
-nab-Paclitaxel


These will be administered in 28-day cycles followed by assessments. There are a lot of details about how and when David gets these drugs. There is more info about this clinical trial at http://www.ClinicalTrials.gov.  Here is the Sponsor/Study Title:
Celgene Corporation/ "An open-label, multicenter, sungle-arm, Phase 1/2 study of metronomic 5-fluorouracil in combination with nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin in patients with metastatic pancreatic adenocarcinoma."


We will keep you posted. 

CaringBridge is a nonprofit social network dedicated to helping family and friends communicate with and support loved ones during a health journey. Learn more about CaringBridge.

To interact with David’s website, sign in or register today.

By registering with CaringBridge, you will join over 300,000 people a day who are supporting friends and family members.

Sign In Or Register
SVG_Icons_Back_To_Top
Top